In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, Biofil Chemicals & Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 12th November 2021, at Registered Office of the Company to transact the following matters: To consider and approve the Un-Audited Financial Results of the Company for the quarter as well as half year ended on 30th September, 2021 along with statement of assets and liabilities and limited review report thereon and Any other matter with the permission of chair.
The above information is a part of company’s filings submitted to BSE.
